The Clorox Company (NYSE:CLX) Shares Sold by Investment House LLC

Investment House LLC cut its stake in The Clorox Company (NYSE:CLX) by 48.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,060 shares of the company’s stock after selling 1,898 shares during the quarter. Investment House LLC’s holdings in Clorox were worth $294,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. Fortitude Family Office LLC acquired a new stake in Clorox during the 4th quarter worth approximately $29,000. Tyler Stone Wealth Management boosted its holdings in Clorox by 64.5% in the 3rd quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares in the last quarter. Hartford Financial Management Inc. increased its position in Clorox by 57.1% during the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after purchasing an additional 93 shares during the period. Valley National Advisers Inc. raised its stake in shares of Clorox by 458.3% during the 4th quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock worth $38,000 after buying an additional 220 shares in the last quarter. Finally, BKM Wealth Management LLC acquired a new stake in shares of Clorox in the 4th quarter valued at approximately $41,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 1.7 %

Shares of Clorox stock opened at $148.92 on Tuesday. The company has a fifty day moving average price of $149.35 and a 200 day moving average price of $142.95. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $178.21. The stock has a market cap of $18.48 billion, a price-to-earnings ratio of 236.38, a price-to-earnings-growth ratio of 2.32 and a beta of 0.43.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.98 EPS. Equities research analysts forecast that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.22%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 761.92%.

Analyst Ratings Changes

Several brokerages have commented on CLX. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. UBS Group boosted their target price on shares of Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, February 2nd. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. The Goldman Sachs Group initiated coverage on shares of Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 target price for the company. Finally, Citigroup reduced their price target on Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 16th. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus price target of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.